Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31409671

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Oct 3
First author
Chen R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Oct 3;134(14):1114-1115. doi: 10.1182/blood.2019002417.
    note
    Source null
    related pmid
    31582369
    relationship
    Comment in

Authors and identifiers

  1. name
    Chen R
    type
    Author
  2. name
    Zinzani PL
    type
    Author
  3. name
    Lee HJ
    type
    Author
  4. name
    Armand P
    type
    Author
  5. name
    Johnson NA
    type
    Author
  6. name
    Brice P
    type
    Author
  7. name
    Radford J
    type
    Author
  8. name
    Ribrag V
    type
    Author
  9. name
    Molin D
    type
    Author
  10. name
    Vassilakopoulos TP
    type
    Author
  11. name
    Tomita A
    type
    Author
  12. name
    von Tresckow B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chen R
    type
    Author
  2. name
    Zinzani PL
    type
    Author
  3. name
    Lee HJ
    type
    Author
  4. name
    Armand P
    type
    Author
  5. name
    Johnson NA
    type
    Author
  6. name
    Brice P
    type
    Author
  7. name
    Radford J
    type
    Author
  8. name
    Ribrag V
    type
    Author
  9. name
    Molin D
    type
    Author
  10. name
    Vassilakopoulos TP
    type
    Author
  11. name
    Tomita A
    type
    Author
  12. name
    von Tresckow B
    type
    Author
bibliography ids
  1. nci-bib-e3f3908267369eabf4a9c231
book metadata
content sha256
d515239dc8e9706f2e0a2d759925afdb8232680a93810cc5da5d3a8f129e3cae
document type
citation
dois
  1. 10.1182/blood.2019000324
electronic publication date
display
2019 Aug 13
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31409671
immutable id
pubmed:31409671@d515239dc8e9706f2e0a2d759925afdb8232680a93810cc5da5d3a8f129e3cae
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
14
name
Blood
nlm unique id
7603509
pages
1144-1153
volume
134
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Oct 3;134(14):1114-1115. doi: 10.1182/blood.2019002417.
    note
    Source null
    related pmid
    31582369
    relationship
    Comment in
outcomes validated
false
pmid
31409671
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
bd928eb222c0b45b6755e56fad1b7f1bfb3dba9cb93795c4e3560329a3433d20
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Oct 3
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31409671/
title
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Preserved source evidence · Not medical advice